| Basic Materials | -- | |
|---|---|---|
| Consumer Cyclical | -- | |
| Financial Services | -- | |
| Real Estate | -- | |
| Consumer Defensive | -- | |
| Healthcare | -- |
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 34.51 | 0.00 (0.00%) | 26.08 - 35.27 | 0.0 |
Market data as of 12:00AM 05/21/13. Quotes are delayed by at least 15 min.
The investment seeks to replicate, net of expenses, the NYSE Arca Equal Weighted Pharmaceutical Total Return Index. The index is designed to track the performance of the equity securities of a cross section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts.
| Open | -- |
|---|---|
| Previous Close | 34.51 |
| Day's Range | -- - -- |
| Avg Volume (10 Day) | 140.0 |
| Total Assets | $5.49M |
| Expense Ratio | 0.60% |
| Yield (Trailing 12 Mo.) | 0.00% |
| Fund Inception | 10/21/2011 |
| Timeframe | DRGS | S&P 500 | Health |
|---|---|---|---|
| 1 Month | 2.59% | 1.93% | 3.38% |
| 3 Month | 7.39% | 7.18% | 10.04% |
| Year-to-Date | 15.26% | 12.74% | 17.90% |
| 1 Year | 21.77% | 16.89% | 26.16% |
| 3 Year | -- | 12.80% | 17.80% |
| 5 Year | -- | 5.21% | 13.29% |
| 10 Year | -- | 7.88% | 8.84% |
| Since Inception | 23.08% | 10.38% | -- |
| Basic Materials | -- | |
|---|---|---|
| Consumer Cyclical | -- | |
| Financial Services | -- | |
| Real Estate | -- | |
| Consumer Defensive | -- | |
| Healthcare | -- |
| Utilities | -- | |
|---|---|---|
| Communication Services | -- | |
| Energy | -- | |
| Industrials | -- | |
| Technology | -- |
| AAA | -- | |
|---|---|---|
| AA | -- | |
| A | -- | |
| BBB | -- |
| BB | -- | |
|---|---|---|
| B | -- | |
| Below B | -- | |
| Not Rated | -- |
| Company | YTD Return | % of Assets |
|---|
| Valuation | DRGS | Category Range |
|---|---|---|
| Price/Earnings | -- | |
| Price/Book | -- | |
| Price/Sales | -- | |
| Price/Cash Flow | -- | |
| Dividend Yield | ||
| LT Earnings | ||
| Historical Earnings | ||
| Sales Growth | ||
| Cash-Flow Growth | ||
| Book-Value Growth |
| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
| Beta | -- |
|---|---|
| Standard Deviation | -- |
| Alpha | -- |
| Sharpe Ratio | -- |
| Mean | -- |
| R-Squared | -- |
| Pretax Return | -- |
|---|---|
| Tax-adjusted Return | -- |
| Tax Cost Ratio | -- |
| Potential Cap Gains | -- |